PCN27 COMPARATIVE BUDGET IMPACT OF FORMULARY INCLUSION OF ZOLEDRONIC ACID AND DENOSUMAB FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES

Saved in:
Bibliographic Details
Published inValue in health Vol. 14; no. 3; p. A159
Main Authors Bell, M.J, Miller, J.D, Namjoshi, M, Russell, M.W
Format Journal Article
LanguageEnglish
Published Elsevier Inc 2011
Subjects
Internal Medicine
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2011.02.885